1. 1. Delaney G, Jacob S, Barton M. Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part II–carcinoma of the endometrium. Cancer. 2004;101(4):682–92.
2. Delaney G, Jacob S, Barton M. Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part I–malignancies of the cervix, ovary, vagina and vulva. Cancer. 2004;101(4):671–81.
3. Heidenreich A, Aus G, Bolla M, Joniau S, Matveev VB, Schmid HP, et al. EAU guidelines on prostate cancer. Eur Urol. 2008;53(1):68–80.
4. Referenced with permission from The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines(r)) for Guideline Testis Cancer V.1.2013. (c) National Comprehensive Cancer Network, Inc 2012. All rights reserved. To view the most recent and complete version of the guideline, go online to www.nccn.org . NATIONAL COMPREHENSIVE CANCER NETWORK(r), NCCN(r), NCCN GUIDELINES(r), and all other NCCN Content are trademarks owned by the National Comprehensive Cancer Network, Inc. Accessed 15 Jan 2013.
5. Referenced with permission from The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines(r)) for Guideline Prostate Cancer V.1.2013. (c) National Comprehensive Cancer Network, Inc 2012. All rights reserved. To view the most recent and complete version of the guideline, go online to www.nccn.org . NATIONAL COMPREHENSIVE CANCER NETWORK(r), NCCN(r), NCCN GUIDELINES(r), and all other NCCN Content are trademarks owned by the National Comprehensive Cancer Network, Inc. Accessed 15 Jan 2013.